Science Speaks is at IDWeek in San Diego, California this week, bringing live coverage of sessions on HIV, TB, Ebola and more. SAN DIEGO, Calif – Despite steady progress made against the HIV pandemic over the past decade, only one third of people living with HIV are on antiretroviral therapy, leaving over 23 million people in need […]
Science Speaks is at IDWeek in San Diego, California this week, bringing live coverage of sessions on HIV, TB, Ebola and more. SAN DIEGO, Calif. – After the HPTN 052 trial settled the question of whether early HIV treatment prevents transmission of the virus, the START trial settled the question of the value of treatment for individual health, Dr. Myron Cohen […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
The Ebola Virus is Winning – This comprehensive analysis by J. Stephen Morrison of the Center for Strategic & International Studies explains how with unprecedented advantages […]